Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Lumenisity, a UK-based fibre optic and cabling supplier aligned to University of Southampton, closed a £7.5m ($9.7m) round on Wednesday led by BGF and featuring Parkwalk Advisors, the fund manager owned by commercialisation firm IP Group. The cash will go to building a new manufacturing and testing plant. Lumensity produces fibre optic cables using a hollow core technology which helps light propagate more effectively.
Ena Respiratory, an Australia-based cold and flu medicine developer at University of Melbourne, has secured A$11.7m ($8.4m) in a round featuring multi-university venturing fund Uniseed that was led by Australian government-backed vehicle Medical Research Commercialisation Fund. The company has identified a small molecule that could serve as a nasal spray to boost the immune system almost immediately in combating the common cold and flu. Ena Respiratory claims the product could be rapidly manufactured should its efficacy be proven during clinical studies given the need for…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?